HK1106445A1 - Melanocortin receptor binding mimetibodies, compositions, methods and uses - Google Patents

Melanocortin receptor binding mimetibodies, compositions, methods and uses

Info

Publication number: HK1106445A1
Authority: HK; Hong Kong
Prior art keywords: methods; receptor binding; compositions; melanocortin receptor; mimetibodies
Prior art date: 2004-10-25

Application number

HK07112011.3A

Other languages

English (en)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Janssen Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2007-11-05

Publication date

2008-03-14

2007-11-05 Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc

2008-03-14 Publication of HK1106445A1 publication Critical patent/HK1106445A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Hematology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Biotechnology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

HK07112011.3A 2004-10-25 2007-11-05 Melanocortin receptor binding mimetibodies, compositions, methods and uses HK1106445A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25
PCT/US2005/038431 WO2006047535A2 (en)	2004-10-25	2005-10-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
HK1106445A1 true HK1106445A1 (en)	2008-03-14

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK07112011.3A HK1106445A1 (en)	2004-10-25	2007-11-05	Melanocortin receptor binding mimetibodies, compositions, methods and uses

Country Status (29)

Country	Link
US (1)	US20060105951A1 (es)
EP (1)	EP1812046B1 (es)
JP (1)	JP2008517605A (es)
KR (1)	KR101255140B1 (es)
CN (1)	CN101437540B (es)
AT (1)	ATE501731T1 (es)
AU (1)	AU2005299440B2 (es)
BR (1)	BRPI0518411A2 (es)
CA (1)	CA2585287A1 (es)
CY (1)	CY1111486T1 (es)
DE (1)	DE602005026970D1 (es)
DK (1)	DK1812046T3 (es)
EA (1)	EA200700944A1 (es)
EC (1)	ECSP077416A (es)
ES (1)	ES2363023T3 (es)
HK (1)	HK1106445A1 (es)
HR (1)	HRP20110405T1 (es)
IL (1)	IL182683A0 (es)
MA (1)	MA28943B1 (es)
ME (1)	ME01234B (es)
MX (1)	MX2007004974A (es)
NO (1)	NO20072499L (es)
PL (1)	PL1812046T3 (es)
PT (1)	PT1812046E (es)
RS (1)	RS51789B (es)
SI (1)	SI1812046T1 (es)
TN (1)	TNSN07157A1 (es)
WO (1)	WO2006047535A2 (es)
ZA (1)	ZA200704260B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) *	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2727317C (en)	2008-06-09	2015-02-17	Palatin Technologies, Inc.	Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US20090305960A1 (en) *	2008-06-09	2009-12-10	Palatin Technologies, Inc	Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
EA020959B1 (ru)	2009-06-08	2015-03-31	Палатин Текнолоджиз, Инк.	Пептиды, специфичные к меланокортиновым рецепторам
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en)	2009-06-08	2010-12-16	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
MX2012005862A (es)	2009-11-23	2012-09-07	Palatin Technologies Inc	Peptidos ciclicos especificos del receptor de melanocortina-1.
BR112012011780A2 (pt)	2009-11-23	2019-09-24	Palatin Technologies, Inc	peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) *	2019-03-02	2020-09-10	上海一宸医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1137340A4 (en)	1998-12-09	2005-12-21	Eleanor Roosevelt Inst	COMPOSITION AND METHODS FOR REGULATION OF BODY WEIGHT AND ASSOCIATED PATHOLOGIES
EP1303625A2 (en) *	2000-07-14	2003-04-23	Zycos Inc.	Alpha-msh related compounds and methods of use
CA2490409A1 (en) *	2002-06-28	2004-01-08	Centocor, Inc.	Mammalian ch1 deleted mimetibodies, compositions, methods and uses
BR0312276A (pt) *	2002-06-28	2005-04-26	Centocor Inc	Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
WO2005097175A2 (en) *	2004-03-31	2005-10-20	Centocor, Inc.	Human glp-1 mimetibodies, compositions, methods and uses

2005
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 RS RS20110230A patent/RS51789B/en unknown
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active IP Right Cessation
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es active Active
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en active Application Filing
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de active Active
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 EP EP05819741A patent/EP1812046B1/en active Active
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
- 2007-11-05 HK HK07112011.3A patent/HK1106445A1/xx not_active IP Right Cessation
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown
- 2011-05-31 HR HR20110405T patent/HRP20110405T1/hr unknown

Also Published As

Publication number	Publication date
US20060105951A1 (en)	2006-05-18
ECSP077416A (es)	2007-05-30
ME01234B (me)	2013-06-20
HRP20110405T1 (hr)	2011-06-30
WO2006047535A2 (en)	2006-05-04
PL1812046T3 (pl)	2011-08-31
ZA200704260B (en)	2009-03-25
RS51789B (en)	2011-12-31
KR101255140B1 (ko)	2013-04-22
DK1812046T3 (da)	2011-06-06
EP1812046A4 (en)	2009-11-11
SI1812046T1 (sl)	2011-06-30
AU2005299440A1 (en)	2006-05-04
JP2008517605A (ja)	2008-05-29
MA28943B1 (fr)	2007-10-01
NO20072499L (no)	2007-07-16
ATE501731T1 (de)	2011-04-15
EP1812046A2 (en)	2007-08-01
EP1812046B1 (en)	2011-03-16
TNSN07157A1 (en)	2008-11-21
IL182683A0 (en)	2007-09-20
ES2363023T3 (es)	2011-07-19
BRPI0518411A2 (pt)	2008-11-18
PT1812046E (pt)	2011-06-28
EA200700944A1 (ru)	2008-04-28
CY1111486T1 (el)	2015-08-05
DE602005026970D1 (de)	2011-04-28
CN101437540A (zh)	2009-05-20
KR20070085416A (ko)	2007-08-27
CN101437540B (zh)	2012-12-19
MX2007004974A (es)	2007-10-17
CA2585287A1 (en)	2006-05-04
AU2005299440B2 (en)	2011-12-15
WO2006047535A3 (en)	2008-09-04

Publication	Publication Date	Title
HK1106445A1 (en)	2008-03-14	Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2007041635A3 (en)	2008-11-13	Fc variants with optimized fc receptor binding properties
WO2007014169A3 (en)	2007-05-10	Anti-cd26 antibodies and methods of use thereof
HUS1800021I1 (hu)	2018-06-28	Humán anti-Il-23 ellenanyagok, készítmények, eljárások és alkalmazások
WO2006083276A3 (en)	2009-04-16	Interferon-alpha polypeptides and conjugates
WO2006105338A3 (en)	2007-03-29	Fc VARIANTS WITH OPTIMIZED PROPERTIES
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
MX348735B (es)	2017-06-27	Celulas madre mesenquimales que expresan los receptores tnf-alfa.
TW200631594A (en)	2006-09-16	Toll like receptor 3 antagonists, methods and uses
IL189555A0 (en)	2008-08-07	Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
WO2007044083A3 (en)	2009-04-16	Evolved interferon-alpha polypeptides
MX2010007716A (es)	2010-08-04	Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas.
TW200745159A (en)	2007-12-16	IL-6 binding proteins
EP1617802A4 (en)	2007-08-01	CNGH0010 SPECIFIC POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP1788649A4 (en)	2010-01-20	BINDER FOR FUEL CELL, COMPOSITION FOR FORMING ELECTRODE, ELECTRODE AND FUEL CELL USING THE ELECTRODE
TW200711846A (en)	2007-04-01	Composite materials and methods of making the same
WO2006018650A3 (en)	2006-04-27	Method of in vitro polypeptide selection using the arc dna binding domain fused to the polypeptide to be selected
MX296535B (es)	2012-02-29	Enzima laccasa novedosa y uso de la misma.
WO2007056760A3 (en)	2008-02-28	Hcv-reactive t cell receptors
EP1828237A4 (en)	2008-06-11	HUMAN CANCER SUPPRESSOR GENE, PROTEIN ENCODED THEREIN, EXPRESSION VECTOR CONTAINING THE GENE, AND CELL TRANSFORMED BY THE VECTOR
SG158098A1 (en)	2010-01-29	Toll like receptor 3 antagonists, methods and uses
EP1844065A4 (en)	2008-08-20	POLYPEPTIDE WITH PYRIDOXIN BIOSYNTHESIS FUNCTION, POLYNUCLEOTIDE FOR CODING THE POLYPEPTIDE AND THEIR USE

Legal Events

Date	Code	Title	Description
2011-11-25	AM	Amended specification (according sect 146 of patent law)	Free format text: CORRECTION OF THE NAME OF APPLICANT FROM JANSSEN BIOTECH INC. TO JANSSEN BIOTECH, INC.. Effective date: 20111116
2018-05-18	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20171025

Date

Code

Title

Description

2011-11-25

Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM JANSSEN BIOTECH INC. TO JANSSEN BIOTECH, INC..

Effective date: 20111116

2018-05-18

Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171025